Clinical trials are essential for evaluating the effectiveness and safety of drugs, devices, services and interventions to help prevent, detect or treat illness and disease. It is through the research done in clinical trials that people gain access to better treatments sooner. Clinical trials also bring hundreds of millions of dollars each year into the Australian economy.
All clinical trials in Australia are assessed and monitored by Human Research Ethics Committees (HRECs).
While the pharmaceutical and biotechnology industries sponsor many of the clinical trials in Australia, there are many that are initiated by researchers and health professionals. NHMRC often funds these types of trials. NHMRC, the Department of Industry, and Department of Health are working together to achieve a nationally consistent approach to the way that clinical trials are conducted, to help promote education and training, and to make it easier for patients to enrol in clinical trials.
If you would like more information on clinical trials in Australia, including those currently underway, visit the Australian Clinical Trials website.
Further information on clinical trials can be found in the ‘Consumer Guide to Clinical Trials’ fact sheet (PDF, 457KB).
The Australian Clinical Trials Environment
Australia’s clinical trials environment is complex, with various responsibilities resting with institutions, private organisations and companies, State or Territory Governments and the Commonwealth Government.
NHMRC Clinical Trials Initiatives
NHMRC and the Department of Industry are undertaking work to improve the clinical trials environment in Australia. NHMRC is working with States, Territories and other stakeholders on a nationally consistent approach to clinical trials.